Nextleaf Solutions Gets Key Canadian Patent and Health Canada Approval For Controlled Human Trials

Article by Steve Darling, Proactive

Nextleaf Solutions (CSE: OILS- OTCQB: OILFF) CEO Paul Pedersen joined Steve Darling from Proactive with news the company has been issued its 70th worldwide patent. This one covers the process for acetylating cannabidiol and subsequent refinement of CBD-O-Acetate using a proprietary extraction and distillation technique.

Pedersen also shared with Proactive, Health Canada has granted the company a research licence to conduct controlled human administration trials for sensory evaluation of cannabis at its processing facility in Metro Vancouver.

Read the full article here.